PropertyValue
?:abstract
  • Deactivation of primed SARS-CoV-2 prior to cell entry constitutes an emergency brake in COVID-19 infection if vaccine-induced antibodies fail to block recognition of the human angiotensin-converting enzyme 2 (hACE2) receptor The timing and locus for the therapeutic intervention are dictated by the cell entry mechanism and by the selective advantage of the dominant D614G mutation
is ?:annotates of
?:creator
?:journal
  • ACS_Pharmacology_&_Translational_Science
?:license
  • unk
?:publication_isRelatedTo_Disease
?:source
  • WHO
?:title
  • Defusing SARS-CoV-2: Emergency Brakes in a Vaccine Failure Scenario
?:type
?:who_covidence_id
  • #872660
?:year
  • 2020

Metadata

Anon_0  
expand all